These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

169 related items for PubMed ID: 18285673

  • 21. Metformin stimulates ischemia-induced revascularization through an eNOS dependent pathway in the ischemic hindlimb mice model.
    Takahashi N, Shibata R, Ouchi N, Sugimoto M, Murohara T, Komori K.
    J Vasc Surg; 2015 Feb; 61(2):489-96. PubMed ID: 24993950
    [Abstract] [Full Text] [Related]

  • 22. Molecular mechanisms of the angiogenic effects of low-energy shock wave therapy: roles of mechanotransduction.
    Hatanaka K, Ito K, Shindo T, Kagaya Y, Ogata T, Eguchi K, Kurosawa R, Shimokawa H.
    Am J Physiol Cell Physiol; 2016 Sep 01; 311(3):C378-85. PubMed ID: 27413171
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Extracorporeal cardiac shock wave therapy markedly ameliorates ischemia-induced myocardial dysfunction in pigs in vivo.
    Nishida T, Shimokawa H, Oi K, Tatewaki H, Uwatoku T, Abe K, Matsumoto Y, Kajihara N, Eto M, Matsuda T, Yasui H, Takeshita A, Sunagawa K.
    Circulation; 2004 Nov 09; 110(19):3055-61. PubMed ID: 15520304
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Induction of angiogenesis by cationic lipid-mediated VEGF165 gene transfer in the rabbit ischemic hindlimb model.
    Gowdak LH, Poliakova L, Li Z, Grove R, Lakatta EG, Talan M.
    J Vasc Surg; 2000 Aug 09; 32(2):343-52. PubMed ID: 10917995
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Repeated thermal therapy up-regulates endothelial nitric oxide synthase and augments angiogenesis in a mouse model of hindlimb ischemia.
    Akasaki Y, Miyata M, Eto H, Shirasawa T, Hamada N, Ikeda Y, Biro S, Otsuji Y, Tei C.
    Circ J; 2006 Apr 09; 70(4):463-70. PubMed ID: 16565566
    [Abstract] [Full Text] [Related]

  • 30. Antiangiogenic effect of angiotensin II type 2 receptor in ischemia-induced angiogenesis in mice hindlimb.
    Silvestre JS, Tamarat R, Senbonmatsu T, Icchiki T, Ebrahimian T, Iglarz M, Besnard S, Duriez M, Inagami T, Lévy BI.
    Circ Res; 2002 May 31; 90(10):1072-9. PubMed ID: 12039796
    [Abstract] [Full Text] [Related]

  • 31. Gene transfer of stromal cell-derived factor-1alpha enhances ischemic vasculogenesis and angiogenesis via vascular endothelial growth factor/endothelial nitric oxide synthase-related pathway: next-generation chemokine therapy for therapeutic neovascularization.
    Hiasa K, Ishibashi M, Ohtani K, Inoue S, Zhao Q, Kitamoto S, Sata M, Ichiki T, Takeshita A, Egashira K.
    Circulation; 2004 May 25; 109(20):2454-61. PubMed ID: 15148275
    [Abstract] [Full Text] [Related]

  • 32. Synergistic effects of FGF-2 and PDGF-BB on angiogenesis and muscle regeneration in rabbit hindlimb ischemia model.
    Li J, Wei Y, Liu K, Yuan C, Tang Y, Quan Q, Chen P, Wang W, Hu H, Yang L.
    Microvasc Res; 2010 Jul 25; 80(1):10-7. PubMed ID: 20045007
    [Abstract] [Full Text] [Related]

  • 33. Endothelial nitric oxide synthase lies downstream from angiotensin II-induced angiogenesis in ischemic hindlimb.
    Tamarat R, Silvestre JS, Kubis N, Benessiano J, Duriez M, deGasparo M, Henrion D, Levy BI.
    Hypertension; 2002 Mar 01; 39(3):830-5. PubMed ID: 11897773
    [Abstract] [Full Text] [Related]

  • 34. Denervation in Femoral Artery-Ligated Hindlimbs Diminishes Ischemic Recovery Primarily via Impaired Arteriogenesis.
    Cen Y, Liu J, Qin Y, Liu R, Wang H, Zhou Y, Wang S, Hu Z.
    PLoS One; 2016 Mar 01; 11(5):e0154941. PubMed ID: 27175510
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Conduction performance of collateral vessels induced by vascular endothelial growth factor or basic fibroblast growth factor.
    Kondoh K, Koyama H, Miyata T, Takato T, Hamada H, Shigematsu H.
    Cardiovasc Res; 2004 Jan 01; 61(1):132-42. PubMed ID: 14732210
    [Abstract] [Full Text] [Related]

  • 37. An endovascular model of ischemic myopathy from peripheral arterial disease.
    Long CA, Timmins LH, Koutakis P, Goodchild TT, Lefer DJ, Pipinos II, Casale GP, Brewster LP.
    J Vasc Surg; 2017 Sep 01; 66(3):891-901. PubMed ID: 27693032
    [Abstract] [Full Text] [Related]

  • 38. Therapeutic angiogenesis following arterial gene transfer of vascular endothelial growth factor in a rabbit model of hindlimb ischemia.
    Takeshita S, Weir L, Chen D, Zheng LP, Riessen R, Bauters C, Symes JF, Ferrara N, Isner JM.
    Biochem Biophys Res Commun; 1996 Oct 14; 227(2):628-35. PubMed ID: 8878563
    [Abstract] [Full Text] [Related]

  • 39. Mouse model of angiogenesis.
    Couffinhal T, Silver M, Zheng LP, Kearney M, Witzenbichler B, Isner JM.
    Am J Pathol; 1998 Jun 14; 152(6):1667-79. PubMed ID: 9626071
    [Abstract] [Full Text] [Related]

  • 40. Synergistic effect of vascular endothelial growth factor and basic fibroblast growth factor on angiogenesis in vivo.
    Asahara T, Bauters C, Zheng LP, Takeshita S, Bunting S, Ferrara N, Symes JF, Isner JM.
    Circulation; 1995 Nov 01; 92(9 Suppl):II365-71. PubMed ID: 7586439
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.